Hospital Pharmacology (Jan 2015)

Ecrin: Needed in European science

  • Marković Srđan Z.,
  • Kastratović Dragana A.,
  • Kubiak Christine,
  • Demotes Mainard Jacques

DOI
https://doi.org/10.5937/hpimj1502279M
Journal volume & issue
Vol. 2, no. 2
pp. 279 – 282

Abstract

Read online

Topic explanation: Modern trends of development in the field of applied science show that the investigator initiated clinical trials are very reliable way of developing and achieving a better quality of health services in all aspects of the organization of health systems. Presenting the topic position to scientific/professional public: ECRIN scientific partner for Serbia is Serbian Medical Society. The three medical areas supported in this project (rare diseases, medical devices, and nutrition) will serve as pilots for other biomedical research fields. For Serbia, the advantages of participating in ECRIN are: a structuring effect on the national clinical research community and infrastructure; a connection to the European infrastructure; allowing projects initiated in Serbian Medical Institutions via SMS to be run throughout the Europe and allowing projects initiated in any European country to be run in Serbia. Conclusion: Permanent cooperation through ECRIN ERIC SMS is a position that enables younger doctors of Serbia the development of science teams in Europe and the world. Time will show whether we will succeed through ECRIN to apply medical knowledge of XXI century.

Keywords